WO2003040383A1 - Obtention de 20-$g(b)-d-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique du ginsenoside - Google Patents
Obtention de 20-$g(b)-d-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique du ginsenoside Download PDFInfo
- Publication number
- WO2003040383A1 WO2003040383A1 PCT/CN2002/000786 CN0200786W WO03040383A1 WO 2003040383 A1 WO2003040383 A1 WO 2003040383A1 CN 0200786 W CN0200786 W CN 0200786W WO 03040383 A1 WO03040383 A1 WO 03040383A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparing
- ginsenodiol
- enzymatic hydrolysis
- type
- hydrolysis
- Prior art date
Links
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 24
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 title claims abstract description 17
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 17
- 230000007071 enzymatic hydrolysis Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title description 2
- 230000007062 hydrolysis Effects 0.000 claims abstract description 15
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 15
- 150000002009 diols Chemical class 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 25
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 239000002244 precipitate Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000237858 Gastropoda Species 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 229930182490 saponin Natural products 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 3
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 claims description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims 9
- 235000017709 saponins Nutrition 0.000 claims 9
- 239000000344 soap Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000003147 glycosyl group Chemical group 0.000 abstract 1
- 239000012452 mother liquor Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000007981 phosphate-citrate buffer Substances 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- -1 ginsenoside K compound Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 2
- 108010001078 naringinase Proteins 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- BDRTVPCFKSUHCJ-UHFFFAOYSA-N molecular hydrogen;potassium Chemical compound [K].[H][H] BDRTVPCFKSUHCJ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
Definitions
- the present invention relates to the preparation of 20- ⁇ -D-glucopyranosylprotopanaxadiol from ginsenosides.
- C-K Compound-K
- Ginsenoside c- ⁇ is a metabolite of diol-type ginsenosides in the intestine after oral administration. Studies have shown that c- ⁇ has antitumor and immunomodulatory effects, improves microcirculation, regulates digestive functions, soothe the nerves, anti-aging, anti-aging Various biological activities such as stress, prevention of gastrointestinal ulcers, improvement of quality of life, enhancement of memory and learning ability. Therefore, c- ⁇ production methods have attracted much attention. Kyobashi Kobashi (Chem Pharm Bull 21 (3): 245-249, 1988) dissolved 500 mg of ginsenoside Rbl and 250 mg of naringinase in 32 ml of phosphate buffer solution (pH 4.0, containing 10% ethanol).
- reaction solution was centrifuged into a precipitate and a mother liquor, and the precipitate was dissolved in 3.5 ml of ethanol, and added to the mother liquor with 32 ml of a buffer solution and 250 mg of naringinase. Hydrolyzed for 7 days.
- the reaction solution was extracted with ether, and the ether phase was evaporated to dryness to obtain ginsenoside C-K.
- the mother liquor was extracted with n-butanol, and the n-butanol phase was washed with water, dried, and evaporated to obtain a residue; the residue was separated by preparative TLC to separate C-K; and combined C-K to obtain 253 mg.
- This method has a high yield (86%), but has the following disadvantages: long hydrolysis time; large amount of enzyme, and the source of the enzyme is inconvenient and uneconomical; it requires extraction with explosive ether, so it is not suitable for mass production .
- Technical content of the invention :
- the present invention provides a method for preparing CK by enzymatic hydrolysis of ginsenosides, including hydrolysis and collection steps, and is characterized in that the diol is hydrolyzed by a snail enzyme in a buffer solution.
- Type ginsenoside the weight ratio of diol type ginsenoside to snail enzyme is 1: 1 ⁇ 10: 1, pH value is between 4.0 ⁇ 5.0, hydrolysis temperature is 30 ⁇ 45 ° C, and hydrolysis time is 2 ⁇ 3 days.
- the collecting process is as follows: the reaction precipitate is washed with water and then repeatedly washed with ethanol. After the combined ethanol solutions were evaporated to dryness, the collected residue was C-K.
- the washing liquid can be combined with the mother liquor and concentrated for reuse in enzymatic hydrolysis.
- the snail enzyme used may be a crude snail enzyme.
- the optimum temperature for hydrolyzing diol-type ginsenosides by crude snail enzyme is 40 ° C, and the optimum pH is 4.5.
- the type of buffer solution has little effect on the enzyme activity.
- the pH of the invention is 4.5. Phosphoric acid-citrate buffer with a strength of 0.01.
- a certain amount of organic solvent should be added to the reaction solution.
- the organic solvent assists the intermediate product to facilitate the normal progress of the enzymatic hydrolysis reaction.
- the type and amount of organic solvents are based on those that do not affect enzyme activity. After screening, 5 ⁇ 15% ethanol is the best.
- the ratio of diol saponin to enzyme is 6: 1; generally speaking, after 8 hours of hydrolysis, the hydrolysis time is prolonged, and the yield of CK is extremely increased. Less, so it is not necessary to lengthen the hydrolysis time.
- the invention provides a convenient and low-cost enzyme for preparing ginsenoside C-K by enzymatic hydrolysis of ginseng glycol saponin.
- the process for preparing C-K using this enzyme is simple, convenient, low cost and high recovery rate.
- the C-K content prepared by this method is 95%, and the aglycon yield is 91%.
- FIG. 1 shows the effect of pH on C-K production
- Figure 2 shows the effect of material ratio on C-K output
- FIG. 3 shows the effect of temperature on C-K production
- Figure 4 shows the effect of ionic strength on C-K production
- FIG. 5 shows the change of C-K output over time
- Example 1 '500 mg of diol-type ginsenoside, 84 mg of snail enzyme was dissolved in 32 ml of phosphate-citrate buffer (pH 4.5, ionic strength 0.01, containing 10% ethanol), and hydrolyzed in a water bath at 40 ° C for 1 day The reaction solution was collected by centrifugation. The precipitate was repeatedly washed with water (10ml X 3). The washing solution was combined with the mother liquor and concentrated to 32ml for reuse. The precipitate was repeatedly washed with ethanol (10ml X 5). The ethanol solution was combined, evaporated to dryness, and collected. The residue gave 106 mg of CK.
- phosphate-citrate buffer pH 4.5, ionic strength 0.01, containing 10% ethanol
- Diol ginsenoside and snail enzyme were dissolved in 3.2ml phosphate-citrate buffer (pH4.5, ionic strength 0.01, containing 10% ethanol) in different proportions, and hydrolyzed in a 40 ° C water bath for 1 day; reaction The precipitate was collected by centrifugation. The precipitate was repeatedly washed with water (lml X 3). The washing solution was combined with the mother liquor and concentrated to 3.2 ml for reuse. The precipitate was repeatedly washed with ethanol (lml X 5). The ethanol solution was combined, evaporated to dryness, and the residue was collected. The CK yield is shown in Figure 2.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
La présente invention concerne un procédé d'obtention de 20-β-D-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique de ginsenoside suivie d'une opération de recueil. La caractéristique du procédé est que le diol se détache du glycosyle moléculaire du ginsenoside et migre vers un site sous l'effet de l'hélice d'enzyme, produisant ainsi l'hélice d'enzyme du composé attendu, en l'occurrence le 20-β-D-pyranoglucosyl-protopanaxadiol. L'hélice d'enzyme utilisé dans l'invention est facilement disponible et bon marché. Le procédé d'obtention du C-K est simple, commode, bon marché, et d'un bon rendement. Il peut se prêter à la préparation d'un médicament anti-tumoral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01133410.X | 2001-11-06 | ||
CNB01133410XA CN1167805C (zh) | 2001-11-06 | 2001-11-06 | 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003040383A1 true WO2003040383A1 (fr) | 2003-05-15 |
Family
ID=4671790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2002/000786 WO2003040383A1 (fr) | 2001-11-06 | 2002-11-05 | Obtention de 20-$g(b)-d-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique du ginsenoside |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1167805C (fr) |
WO (1) | WO2003040383A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1508146A (zh) * | 2002-12-13 | 2004-06-30 | 中国科学院大连化学物理研究所 | 一种新型抗肿瘤人参皂苷 |
CN1305479C (zh) * | 2003-09-28 | 2007-03-21 | 中国科学院大连化学物理研究所 | 具有抗肿瘤活性的低极性人参皂苷组合物 |
US8541035B2 (en) | 2009-05-14 | 2013-09-24 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
JP6170674B2 (ja) * | 2009-05-19 | 2017-07-26 | イル・ファ・カンパニー・リミテッドIl Hwa Co.,Ltd. | 発酵高麗人参濃縮液または粉末の製造方法 |
CN101768619A (zh) * | 2010-02-10 | 2010-07-07 | 华侨大学 | 一种以Rd为底物制备稀有人参皂甙IH-901的方法 |
CN102154417A (zh) * | 2010-12-13 | 2011-08-17 | 天津中医药大学 | 一种杠柳次苷的制备方法 |
CN102251009A (zh) * | 2011-06-09 | 2011-11-23 | 华侨大学 | 一种稀有人参皂甙ih-901结晶的简易生产方法 |
CN103360441B (zh) * | 2012-04-01 | 2016-08-10 | 浙江海正药业股份有限公司 | 人参皂苷c-k化合物多晶型及其制备方法 |
CN105949264A (zh) * | 2012-04-01 | 2016-09-21 | 浙江海正药业股份有限公司 | 人参皂苷c-k的两种晶型及其制备方法 |
CN103073611B (zh) * | 2013-01-10 | 2015-10-28 | 天津大学 | 一种人参皂苷c-k半水合物晶体及制备方法 |
CN104622928A (zh) * | 2015-01-04 | 2015-05-20 | 中国药科大学 | 人参总皂苷通过激活IL-1β/IL-18活化分泌发挥免疫调节作用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648946A (ja) * | 1991-06-21 | 1994-02-22 | Takuo Kosuge | サポニン誘導体を含有する補気薬 |
CN1184851A (zh) * | 1996-11-29 | 1998-06-17 | 株式会社一和 | 人参皂草苷代谢物的制备方法 |
CN1190098A (zh) * | 1998-01-22 | 1998-08-12 | 白求恩医科大学基础医学院 | 人参分组皂甙的制备方法,其药物组合物及应用 |
-
2001
- 2001-11-06 CN CNB01133410XA patent/CN1167805C/zh not_active Expired - Fee Related
-
2002
- 2002-11-05 WO PCT/CN2002/000786 patent/WO2003040383A1/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648946A (ja) * | 1991-06-21 | 1994-02-22 | Takuo Kosuge | サポニン誘導体を含有する補気薬 |
CN1184851A (zh) * | 1996-11-29 | 1998-06-17 | 株式会社一和 | 人参皂草苷代谢物的制备方法 |
CN1190098A (zh) * | 1998-01-22 | 1998-08-12 | 白求恩医科大学基础医学院 | 人参分组皂甙的制备方法,其药物组合物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1417345A (zh) | 2003-05-14 |
CN1167805C (zh) | 2004-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100377546B1 (ko) | 효소적 방법에 의한 진세노사이드 컴파운드 케이의 제조방법 | |
WO2003040383A1 (fr) | Obtention de 20-$g(b)-d-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique du ginsenoside | |
JP2004519224A (ja) | ジンセノサイド糖基を加水分解するジンセノサイドグリコシダーゼ及びその使用 | |
CN107746871B (zh) | 利用裂褶菌生物转化人参皂苷制备人参稀有皂苷的方法 | |
CN106755214B (zh) | 一种双相酶水解获取宝藿苷i的方法 | |
JPS6312300A (ja) | ジンセノサイド−Rdの製造法 | |
KR100420451B1 (ko) | 셀룰라제 또는 락타제 조성물 와이-에이오를 이용한진세노사이드 컴파운드 케이의 제조방법 | |
CN118995867A (zh) | 一种红发夫酵母产虾青素的方法 | |
CN118028179A (zh) | 一种枯草芽孢杆菌和生产阿洛酮糖的方法及其应用 | |
CN108570016B (zh) | 一种pf1022a分离纯化的方法 | |
CN113754626A (zh) | 一种酶法制备漆黄素的方法 | |
CN109234347B (zh) | 一种转化原人参三醇型皂苷生成c25-oh衍生物的方法 | |
CN101962397A (zh) | 生物转化液中分离纯化2'-脱氧腺苷的方法 | |
CN101481725A (zh) | 酶促水解人参皂苷Rb1制备人参皂苷F2的方法 | |
KR20170112637A (ko) | 장수버섯 균사체를 이용한 희귀 인삼 사포닌의 제조방법 | |
KR100654172B1 (ko) | 효소반응에 의한 진세노사이드 Mc 및 진세노사이드Mc-1의 제조방법 | |
CN114736257B (zh) | 一种从含尿苷的催化液中分离提取尿苷的方法 | |
JP2992830B2 (ja) | 新規β―グルクロニダーゼ | |
JPH08119986A (ja) | シアル酸またはその類縁体の精製方法 | |
KR100318304B1 (ko) | 진세노사이드알지1의제조방법 | |
JP2887689B2 (ja) | グリチルレチン酸モノグルクロナイドの製造法 | |
JPS62293A (ja) | L−ラムノ−スの製造法 | |
EP0240741A2 (fr) | Procédé de préparation d'inulase | |
JPS6398399A (ja) | リボフラビンの取得方法 | |
US3385764A (en) | Process for preparation of fusafungine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP KR US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |